Delivery Order SPE2DB20D2104-SPE2DB23FT70T
Award Date 5/26/23
Potential Completion Date 5/30/23
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,503.92 firm fixed-price contract is for the supply of the medication Microgestin Fe 1-20 Tablet 28s. The contract has an ultimate completion date of December 28, 2022 and is not designated as a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,461.30 firm fixed-price contract is for the delivery of MICROGESTIN FE 1-20 TABLETS 28S, a pharmaceutical product. The contract is not set aside and was awarded on May 20, 2025, with an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the place of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract covers the supply of the pharmaceutical product Microgestin FE 1-20 Tablet 28s, with a total ceiling value of $6,454.47. The contract is a firm fixed-price delivery order, with an ultimate completion date of February 11, 2022. The award was made on February 10, 2022, and there was no set-aside designation used....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, with a ceiling value of $1,461.30 and a completion date of June 17, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MICROGESTIN FE 1.5-30 TAB 28S. The award has a ceiling value of $3,705.83 and a completion date of July 28, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,235.75, is for the delivery of MICROGESTIN FE 1-20 TABLET 28S. The contract has an ultimate completion date of April 10, 2024 and a firm fixed price pricing type. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization, is the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,045.23, is a delivery order for the supply of MICROGESTIN FE 1-20 Tablets, a generic contraceptive medication. This contract is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,305.90 firm-fixed-price delivery order is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a prescription medication. The contract award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for...
- This $1,432.59 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide MICROGESTIN FE 1.5-30 TAB 28S. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the for-profit organization Cencora, Inc., doing business as AmerisourceBergen. The $1,361.76 order is for the supply of MICROGESTIN FE 1.5-30 TAB 28S pharmaceutical products, with a completion date of January 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on a larger indefinite delivery contract...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT70TDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,048.51 contract is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a contraceptive medication. The award has a completion date of May 30, 2023 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC contract.
Generated 2/27/25, 11:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 5/26/23 |